Epicardial and microvascular reperfusion with primary percutaneous coronary intervention

Italian Heart Journal

Volumn 6, Issue 6, 2005, Pages 447-452

  Bolognese, Leonardo ^a   Falsini, Giovanni ^a   Liistro, Francesco ^a   Angioli, Paolo ^a   Ducci, Kenneth ^a  

^a Arezzo Hospital   (Italy)

Author keywords

Coronary angioplasty; Microvascular dysfunction; Myocardial infarction

Indexed keywords

ANGIOCARDIOGRAPHY; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; HEART INFARCTION; HUMAN; METHODOLOGY; MICROCIRCULATION; PATHOPHYSIOLOGY; PERICARDIUM; PHYSIOLOGY; RADIOGRAPHY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; PERICARDIUM; TREATMENT OUTCOME;

EID: 26944449742     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
2. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling following primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002; 106: 2351-7.
3. Bolognese L, Carrabba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109: 1121-6.
4. Topol EJ. Current status and future prospects for acute myocardial infarction therapy. Circulation 2003; 108 (Suppl 1): III6-III13.
5. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-705.
6. Anselmi M, Bolognese L, Chierchia S, Maggioni A, Marino P. The role of myocardial viability in deriving benefit from reestablishing infarct-related artery flow after acute myocardial infarction. Prog Cardiovasc Dis 2000; 42: 455-70.
7. Roe MT, Ohman EM, Maas AC, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001; 37: 9-18.
8. Anderson JL, Karagounis LA, Becker LC, Sorensen SG, Menlove RL. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction: ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study. Circulation 1993; 87: 1829-39.
9. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932-6.
10. Gibson CM, Ryan KA, Kelley M, et al. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J 1999; 137: 1179-84.
11. Gibson CM, Murphy S, Menown IB, et al. Determinants of coronary blood flow following thrombolytic administration. TIMI Study Group. J Am Coll Cardiol 1999; 34: 1403-12.
12. Gibson CM, Schömig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation 2004; 109: 3096-105.
13. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-80.
14. Tanaka A, Kawarabayashi T, Nishibori Y, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105: 2148-52.
15. Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 2000; 85: 50B-60B.
16. Lindner JR, Song J, Jayaweera AR, Sklenar J, Kaul S. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 2002; 15: 396-403.
17. Johnson WB, Malone SA, Pantley GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988; 78: 462-72.
18. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994; 89: 2562-9.
19. Sakuma T, Hayashi Y, Sumii K, Imazu M, Yamakido M. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998; 32: 890-7.
20. White FC, Sanders M, Bloor CM. Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog. Am J Cardiol 1978; 42: 234-43.
21. Kaul S, Pandian NG, Guerrero JL, Gillam LD, Okada RD, Weyman AE. The effects of selectively altering the collateral driving pressure on regional perfusion and function in the occluded coronary bed in the dog. Circ Res 1987; 61: 77-85.
22. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining the extent of myocardial salvage. Circulation 1993; 88: 2596-606.
23. Bolognese L, Antoniucci D, Rovai D, et al. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996; 28: 1677-83.
24. Iliceto S, Galiuto L, Marchese A, et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996; 77: 441-5.
25. Brochet E, Czitrom D, Karila-Cohen D, et al. Early changes in myocardial perfusion patterns after myocardial infarction: relation with contractile reserve and functional recovery. J Am Coll Cardiol 1998; 32: 2011-7.
26. Sciagrà R, Bolognese L, Rovai D, et al. Detecting myocardial salvage after primary PTCA: early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging. J Nucl Med 1999; 40: 363-70.
27. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000; 102: 2745-50.
28. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002; 105: 1764-7.
29. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302-6.
30. Costantini CO, Stone GW, Mehran R, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004; 44: 305-12.
31. Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 1996; 94: 1269-75.
32. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003; 107: 3129-32.
33. Schröder K, Wegscheider K, Zeymer U, Tebbe U, Schröder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001; 358: 1479-86.
34. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004; 110: e506-e510.
35. Haager PK, Christott P, Heussen N, Lepper W, Hanrath P, Hoffmann R. Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion. J Am Coll Cardiol 2003; 41: 532-8.
36. Dibra A, Mehilli J, Dirschinger J, et al. Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. J Am Coll Cardiol 2003; 41: 925-9.
37. Gibson CM, Karha J, Giugliano RP, et al. for the INTEGRITI Study Group. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. Am Heart J 2004; 147: 847-52.
38. Kandzari DE, Hasselblad V, Tcheng JE, et al. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J 2004; 147: 457-62.
39. Wang HJ, Lo PH, Lin JJ, Lee H, Hung JS. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2004; 63: 171-6.
40. Taniyama Y, Ito H, Iwakura Y, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1193-9.
41. Kloner RA, Rezkalla SH. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 2004; 44: 276-86.
42. Marzilli M, Orsini E. Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101: 2154-9.
43. Mahaffey KW, Puma JA, Barbagelata. NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial - the Acute Myocardial Infarction Study of Adenosine (AMISTAD) trial. J Am Coll Cardiol 1999; 34: 1711-20.
44. Ross A, Gibbons IR, Kloner RA, et al. Acute myocardial infarction study of adenosine (AMISTAD II). (abstr) J Am Coll Cardiol 2002; 39 (Suppl A): 338A.
45. Sato T, Sasaki N, O'Rourke B, Marban R. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 2000; 35: 514-8.
46. Ito H, Taniyama Y, Iwakura & et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-60.
47. Ono H, Osanai T, Ishizaka H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J 2004; 148: E15.
48. Stone GW, Webb J, Cox DA, et al, for the Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005; 293: 1063-72.
49. Dixon SR, Bartorelli AL, Marcovitz PA, et al. Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction: results of a pilot study utilizing intracoronary aqueous oxygen therapy. J Am Coll Cardiol 2002; 39: 387-92.